Quick Answer
CHAMPIONS ONCOLOGY, INC. reported Cash and Equivalents of $3.24 million for fiscal year 2019.
CHAMPIONS ONCOLOGY, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2019 | $3.24M | +278.2% |
| 2018 | $856.0K | -74.0% |
| 2017 | $3.29M | +27.5% |
| 2016 | $2.58M | -72.4% |
| 2015 | $9.36M | +58.8% |
| 2014 | $5.89M | -38.4% |
| 2013 | $9.56M | +101.1% |
| 2012 | $4.75M | -54.5% |
| 2011 | $10.46M | +306.6% |
| 2010 | $2.57M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $7.13M | +122.6% | -16.3% |
| October 31, 2025 | $8.52M | +209.2% | -17.5% |
| July 31, 2025 | $10.32M | +257.0% | +5.5% |
| April 30, 2025 | $9.79M | +273.8% | +205.6% |
| January 31, 2025 | $3.20M | -28.3% | +16.3% |
| October 31, 2024 | $2.75M | -50.0% | -4.8% |
| July 31, 2024 | $2.89M | -40.6% | +10.5% |
| April 30, 2024 | $2.62M | -74.1% | -41.4% |
- CHAMPIONS ONCOLOGY, INC. showed an increase of +278.2% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2010–2019 period, CHAMPIONS ONCOLOGY, INC.’s cash and equivalents has grown by 25.9% (from $2.57 million to $3.24 million).
- The most recent figure is from CHAMPIONS ONCOLOGY, INC.’s fiscal year 2019 report (Form 10-K), filed with the SEC on July 29, 2019.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: